Effect of the E4 region on the persistence of transgene expression from adenovirus vectors

被引:147
作者
Armentano, D
Zabner, J
Sacks, C
Sookdeo, CC
Smith, MP
StGeorge, JA
Wadsworth, SC
Smith, AE
Gregory, RJ
机构
[1] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT INTERNAL MED,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242
关键词
D O I
10.1128/JVI.71.3.2408-2416.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The utility of adenovirus vectors for gene therapy is limited by the transience of expression that has been observed in various in vivo models. Immunological responses to viral targets can eliminate transduced cells and cause the loss of transgene expression. We previously described the characterization of an E4 modified adenovirus, Ad2E4ORF6, which is replication defective in cotton fats. We reasoned that gene transfer vectors based on Ad2E4ORF6 would have a reduced potential for viral gene expression in vivo which might be beneficial for achieving persistence of transgene expression. E1 replacement vectors expressing the cystic fibrosis transmembrane regulator or beta-galactosidase were constructed as series of vectors that differed with respect to the E4 region. Vectors containing a wild-type E4 region, E4 open reading frame 6, or a complete E4 deletion were compared in the lungs of BALB/c mice for persistence of expression. Results obtained with nude mice indicate that nonimmunological factors have a major influence on the longevity of transgene expression. Expression was transient from the E1a promoter with all vectors but persisted from the cytomegalovirus promoter only with a vector containing a wild-type E4 region. Transience of expression did not correlate with the disappearance of vector DNA, suggesting that promoter down-regulation may be involved. Coinfection studies indicate an E4 product(s) could be supplied in trans to allow persistent expression from the cytomegalovirus promoter. In summary, the choice of promoter is important for achieving persistence of expression; in addition, some promoters are highly influenced by the context of the vector backbone.
引用
收藏
页码:2408 / 2416
页数:9
相关论文
共 36 条
  • [1] CHARACTERIZATION OF AN ADENOVIRUS GENE-TRANSFER VECTOR CONTAINING AN E4 DELETION
    ARMENTANO, D
    SOOKDEO, CC
    HEHIR, KM
    GREGORY, RJ
    STGEORGE, JA
    PRINCE, GA
    WADSWORTH, SC
    SMITH, AE
    [J]. HUMAN GENE THERAPY, 1995, 6 (10) : 1343 - 1353
  • [2] BARR D, 1995, GENE THER, V2, P151
  • [3] The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice
    Baskar, JF
    Smith, PP
    Nilaver, G
    Jupp, RA
    Hoffmann, S
    Peffer, NJ
    Tenney, DJ
    ColbergPoley, AM
    Ghazal, P
    Nelson, JA
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (05) : 3207 - 3214
  • [4] BERKNER KL, 1988, BIOTECHNIQUES, V6, P616
  • [5] HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS - A BIOCHEMICAL AND FINE STRUCTURAL STUDY
    BERRY, MN
    FRIEND, DS
    [J]. JOURNAL OF CELL BIOLOGY, 1969, 43 (03) : 506 - +
  • [6] ADENOVIRUS EARLY REGION-4 AND VIRAL-DNA SYNTHESIS
    BRIDGE, E
    MEDGHALCHI, S
    UBOL, S
    LEESONG, MS
    KETNER, G
    [J]. VIROLOGY, 1993, 193 (02) : 794 - 801
  • [7] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [8] Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor
    Dobner, T
    Horikoshi, N
    Rubenwolf, S
    Shenk, T
    [J]. SCIENCE, 1996, 272 (5267) : 1470 - 1473
  • [9] Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure
    Doucas, V
    Ishov, AM
    Romo, A
    Juguilon, H
    Weitzman, MD
    Evans, RM
    Maul, GG
    [J]. GENES & DEVELOPMENT, 1996, 10 (02) : 196 - 207
  • [10] PROLONGED TRANSGENE EXPRESSION IN COTTON RAT LUNG WITH RECOMBINANT ADENOVIRUSES DEFECTIVE IN E2A
    ENGELHARDT, JF
    LITZKY, L
    WILSON, JM
    [J]. HUMAN GENE THERAPY, 1994, 5 (10) : 1217 - 1229